Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Cisplatin in Metastatic Renal Cell Carcinoma
NCT00003928Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Jan 1999
- Primary completion
- Feb 2005
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, Cisplatin micelle injection (HA132) in renal cell carcinoma (RCC), sponsored by Case Comprehensive Cancer Center. Started Jan 1999; status: completed.
02
Drugs
gemcitabineCisplatin micelle injection (HA132)
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00003928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003928.